← Leaderboards
Jared Shane Bushman
Rutgers, The State Univ Of N.J.
$1,659,409
Attributed
$3,159,041
Total exposure
4
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $917.7K · FY2012–25$1M$750K$500K$250K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,159,041 · 4
By mechanism
R01$1,980,377 · 1
R21$815,488 · 2
P20$363,176 · 1
Top collaborators
- George Davis Bittner5 shared
- Mark Gomelsky2 shared
- Melitta Schachner2 shared
- Jaimie T Shores1 shared
Most similar at Rutgers, The State Univ Of N.J.
Same institution · by research overlap
- David Ira Shreiber$1,186,695
- Melitta Schachner$967,625
Others in their field
Top investigators on “Injury”
- Polly Chang · Sri International$119,352,977
- Marco Pahor · Wake Forest University Health Sciences$82,312,292
- Kerry J Kelly · New York City Fire Department$81,924,266
- Asrar B. Malik · University Of Illinois At Chicago$81,164,529
- Peter Scott Heeger · Case Western Reserve University$76,259,223
- Jacqueline Moline · Icahn School Of Medicine At Mount Sinai$75,762,106
Research focus
InjuryNatural RegenerationRepairedCellsTissuesFunctional DisorderAnimal ModelNerve RegenerationMyelinRattusFunctional ImprovementNerve GapPeripheral Nerve InjuryTechnologyDevicesPharmaceutical PreparationsBehaviorImmune ResponseNerveCostDefectAxonPeripheral NervesRecovery
Grant awards (11)
Translating Novel Peripheral Nerve Allograft Technologies Toward Clinical Use$608,885
R01 · FY2025 · NS
Near-infrared light controlled transplanted cells to treat spinal cord injury$216,750
R21 · FY2025 · NS
Translating Novel Peripheral Nerve Allograft Technologies Toward Clinical Use$92,072
R01 · FY2025 · NS
Translating Novel Peripheral Nerve Allograft Technologies Toward Clinical Use$589,701
R01 · FY2024 · NS
Near-infrared light controlled transplanted cells to treat spinal cord injury$180,625
R21 · FY2024 · NS
Translating Novel Peripheral Nerve Allograft Technologies Toward Clinical Use$79,521
R01 · FY2024 · NS
Translating Novel Peripheral Nerve Allograft Technologies Toward Clinical Use$610,198
R01 · FY2023 · NS
Delineating and modulating the gliotic changes occurring after spinal cord injury$181,588
P20 · FY2021 · GM · contact PI
Delineating and modulating the gliotic changes occurring after spinal cord injury$181,588
P20 · FY2020 · GM · contact PI
Retasking an FDA-approved Drug for use in Peripheral Nerve Regeneration$224,363
R21 · FY2013 · NS
Retasking an FDA-approved Drug for use in Peripheral Nerve Regeneration$193,750
R21 · FY2012 · NS